-
Product Insights
Cardiac Marker Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Marker Tests Pipeline Market Overview A cardiac marker test is a biomarker test used to diagnose cardiac diseases. The Cardiac Marker Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Other Cardiac Marker...
-
Product Insights
NewOrtho Clinical Diagnostics Holdings Plc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Ortho Clinical Diagnostics Holdings Plc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Ortho Clinical Diagnostics Holdings Plc (OCD) designs, develops, manufactures, and markets diagnostic instruments, assays. It offers its products and solutions to hospitals, clinical laboratories, blood, and plasma centers across the world. The company’s products include clinical chemistry products used for measurement of target chemicals in bodily fluids for the evaluation of health and the clinical management of...
-
Product Insights
NewOncoStem Diagnostics Pvt. Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our OncoStem Diagnostics Pvt. Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. OncoStem Diagnostics Pvt Ltd (OncoStem) is a developer of cancer recurrence test solutions. The company develops multimaker prognostic and predictive testing enabling detecting and treating patients affected with cancer. It develops various tests in identifying patterns of repetition in cancer. OncoStem's CanAssist-Breast identifies the risk of recurrence in patients having hormone receptor positive breast cancer. OncoStem targets developing...
-
Product Insights
NewDermTech Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our DermTech Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. DermTech Inc (DermTech) is a genomics company that develops, manufactures and markets non-invasive precision dermatology solutions. It offers melanoma test that non-invasively detects the presence of genomic markers associated with melanoma by identifying changes in skin’s RNA (ribonucleic acid) and DNA (deoxyribonucleic acid). The company utilizes Smart Stickers to lift and collect skin cells from a suspicious skin spot. DermTech...
-
Product Insights
NewAtomo Diagnostics Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Atomo Diagnostics Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Atomo Diagnostics Ltd (Atomo ) is a medical device company that designs, develops, manufactures, and commercializes in-vitro diagnostic products. The company offers AtomoRapid HIV, a human immunodeficiency virus (HIV) rapid test kit; and AtomoRapid malaria, a kit to test malaria infections. Its products are used for self-test consumer applications for detecting infectious diseases, measuring markers and hormone levels, and...
-
Product Insights
NewGenetic Technologies Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Genetic Technologies Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Genetic Technologies Ltd (GTG) is a molecular diagnostic company that offers testing products and services to assess sporadic breast cancer risk and colorectal cancer risk assessment. It delivers the offerings by GeneType for breast cancer tests and GeneType test for colorectal cancer. GeneType for breast cancer, a test that examines woman’s clinical risk factors with scientifically validated genetic biomarkers,...
-
Product Insights
NewQuanterix Corp Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Quanterix Corp Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Quanterix Corp (Quanterix) is a life sciences company that develops and markets an ultra-sensitive digital immunoassay platform. It offers a biomarker detection system, antibodies and ELISA kits, bead-based immunoassay platform, and homebrew assays. Quanterix provides protein biomarker testing and custom assay development services. It markets diagnostics technology under the brands of Simoa, HD-X Analyzer, SR-X, SP-X Imaging and Analysis System,...
-
Product Insights
NewQuidel Corp Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Quidel Corp Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Quidel Corp (Quidel) is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays, molecular assays, virology products including traditional cell lines, specimen collection devices, media and controls; and specialty products including metabolic bone markers and enzyme linked immunosorbent assays (ELISA)...
-
Product Insights
Likelihood of Approval Analysis for Inflammatory Pain
Overview How likely is it that the drugs in Inflammatory Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Inflammatory Pain Overview Inflammatory pain stems from the body's response to injury,...
-
Product Insights
Likelihood of Approval Analysis for Endocrine Gland Disorders
Overview How likely is it that the drugs in Endocrine Gland Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Endocrine Gland Disorders Overview Endocrine gland disorders are medical conditions that...